“When 238 rare-disease doctors across the U.S. were surveyed by a research team at Mass General Brigham in Boston, 88% of them agreed that DNA sequencing to screen for certain treatable childhood disorders should be made available to all newborns. The study was published Monday in JAMA Network Open.”
“Findings from a new study led by researchers at Mass General Brigham suggest that rare disease experts are now in favor of more expansive newborn testing. In a study published today in JAMA Network Open, 88 percent of rare disease experts agreed that DNA sequencing to screen for treatable childhood disorders should be made available … Continued
Families that participated in the BabySeq Project share their stories and experiences in this short video.
Families that participated in the BabySeq Project share their stories and experiences in this short video.
“In our Five-Question series, we highlight the staff and faculty behind the compelling work at Ariadne Labs. Upstream or downstream? That has long been a career question for Nic Encina, MS, MS, MBA, now Director of Strategy of the Precision Population Health initiative at Ariadne Labs.”
Genomes2People was featured in the latest issue of Brigham Clinical & Research News “Look who’s talking”. Past winners of the Brigham Research Institute’s BRIght Futures Prize share about the impact that the $100,0000 award has had on their work and careers. “In 2012, we were delighted to be the very first winners of the BRIght … Continued
Dr. Robert Green discusses considerations for screening for autism amidst a complicated ethical landscape in an interview with proto.life
Senior Genetic Counselor Carrie Blout Zawatsky, MS, CGC along with a team of esteemed co-authors was recently recognized by the NHGRI genomic medicine working group for the notable accomplishment of developing an Elective genomic testing practice resource.
Robert C. Green, MD, MPH, will speak on a panel concerning newborn genomic screening programs across the globe at the 2023 Frontiers in Pediatric Genomic Medicine hybrid conference taking place in-person at Scripps Seaside Forum in La Jolla, CA and simultaneously streamed live.
We know this screening saves lives. Why aren’t health systems adopting it? Senior Genetic Counselor Carrie Blout Zawatsky explores this question in a new blog.
Dr. Robert Green gives his perspective on Beethoven’s DNA being decoded from centuries-old hair samples in an interview with the Washington Post.
In this newsletter we’re excited to congratulate Sophia Adelson, Erin Drake, and Sheyenne Walmsley for winning the Brigham and Women’s Hospital Pillars of Excellence Awards. We’re also highlighting Carrie Zawatsky for her leadership in publishing NSGC’s first clinical practice resource on elective genetic testing, as well as Dr. Nina Gold’s NIH Mentored Clinical Scientist Research … Continued
Robert C. Green, MD, MPH is Professor of Medicine (Genetics) at Harvard Medical School and a physician-scientist who directs the G2P Research Program at Brigham and Women’s Hospital, Broad Institute and Ariadne Labs. Dr. Green is internationally recognized for research and policy efforts accelerating the implementation of genomic/precision medicine. In this fascinating conversation Nieca and … Continued
Dr. Robert C. Green was invited to speak on the topic of Precision Medicine and Population Genomics on March 9th at the Lake Nona Impact Forum 2023 event. The three-day event took place in Lake Nona Medical City in Orlando, FL, a life sciences and healthcare cluster of excellence featuring some of the Nation’s top … Continued
Robert C. Green, MD, MPH will be joined by David Bick, MD; Richard Scott, MD; Wendy K. Chung, MD and Stephen Kingsmore, MD, DSc presenting at the NBSeq Symposium during the first day of the conference. Close G2P Collaborator at Dartmouth Health Children’s, Nidhi D. Shah, MD, FACMG will present a poster on Perspectives of … Continued
Congratulations to G2P Genetic Counselor Janelle Shea and Operations Coordinator Shaye Williams for being nominated for and winning The Brigham Way Award, which recognizes employees who foster a culture of excellence, respect and professionalism by going above and beyond their duties to create an exceptional Brigham Experience for our patients and colleagues. Janelle celebrated her … Continued
In this Chicago Tribune post, G2P Director Robert Green writes that Hemsworth and Jolie are accelerating awareness and acceptance of a future where we do not wait to respond to the ravages of so many diseases but rather anticipate, predict and prevent them through genomics.
In this newsletter, we are excited to announce the date and location of the 2023 International Conference on Newborn Sequencing (ICoNS) happening the week of October 2nd-6th in London. Additionally, we highlight the professional accomplishments of our Senior Genetic Counselor/Project Manager Carrie Blout Zawatsky, as well as our team at the Annual National Society of … Continued
The lack of diversity in genomic research may be a call to fundamentally change the research enterprise.
WHAM is working to increase awareness of and accelerate funding for women’s health research to transform women’s lives and impact the economy.
Precision Population Health (PPH) aims to bring the power of precision medicine to primary care settings, where it can be used to treat disease or prevent it before it occurs. The initiative combines expertise from Ariadne Labs and Genomes2People, creating a world-class collaboration of clinical genomics experts and implementation scientists to overcome the challenges that … Continued
